On September 17, 2014, the Pharma & Biopharma Outsourcing Association made its official debut in front of FDA at a public hearing to discuss the Generic Drug User Fee Amendments (GDUFA). During an open comments session of the hearing, PBOA President Gil Roth spoke to the panel about our members’ interests in seeing GDUFA’s Facility.
Initial thoughts on the latest M&A action to impact CMOs
It’s a busy season for the PBOA and its members
Fall conference season is done, and it’s time to focus on the 2015 agenda